# Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

> **NCT07736911** · PHASE3 · RECRUITING · sponsor: **Fu Jen Catholic University Hospital** · enrollment: 140 (estimated)

## Conditions studied

- GLP-1

## Interventions

- **DRUG:** GLP-1 Stop for 1 week
- **DRUG:** GLP-1 non stop

## Key facts

- **NCT ID:** NCT07736911
- **Lead sponsor:** Fu Jen Catholic University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-06-01
- **Final completion:** 2030-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736911, "Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*